Navigation Links
New lease of life for asthmatics by Accentia Biopharmaceuticals

Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), through its specialty pharmaceuticals subsidiary, TEAMM Pharmaceuticals, Inc., has developed MD Turbo.// It is the first and only available product that transforms many of the most commonly prescribed metered dose inhalers (MDIs) into breath-activated, dose-counting inhalers. MD Turbo will be available at pharmacies in May of this year.

Gary Cantrell, TEAMM Executive Vice President of Sales and Marketing said, "MDIs are most often used as rescue medications during acute attacks. Improper dosing and other misuses can lead to negative outcomes, such as the exacerbation of symptoms and even hospitalization. But with MD Turbo physicians will be able to prescribe their drug of choice in combination with an easy to use, handheld, breath-activated device to overcome the delivery challenges often facing their patients."

"MDIs have been around for about 50 years. But MD Turbo is the first companion product to solve two of the biggest challenges facing MDI users: coordination of inhaler actuation with patient's breath, and the accounting of how much medication is left in the inhaler. We are all very excited about introducing a new product to the market that can improve the quality of care," said an excited Gil Mott, President and Chief Executive Officer of Respirics Inc.

More than 40 million MDIs are prescribed each year in the United States alone.

So it would be a lease of fresh air for many asthma patients.


'"/>




Page: 1

Related medicine news :

1. Want skin cancer? Please have a cigarette
2. Sweet corn releases antioxidants on cooking
3. Pause as you please
4. Stents That Release Medication To Check Artery Narrowing
5. NABH Health accreditations final draft to be released by this month
6. Chicago: Dad, I need you desperately, Please come back
7. Students Seek Help From Prisoners for Kidnapped Childs Release
8. Indian National in Saudi Jail will be released soon
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
11. An International Growth Standard For Childs Releases By WHO
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Alexandria, Virginia (PRWEB) , ... March 23, 2017 ... ... quality public health services to their communities, 16 more public health departments have ... This week’s decisions bring another 4.5 million people into the expanding network of ...
(Date:3/23/2017)... ... March 23, 2017 , ... 82% of adults are unaware of the dangers that infectious ... their teeth the minimum two times a day that dentists recommend. The ramifications of improper ... hours of school and adults missing 164 million hours of work each year due to ...
(Date:3/23/2017)... ... March 23, 2017 , ... Hakim ... based healthcare technology company California Healthcom Group (CHG). , The HUG investment ... arena. With headquarters in California, CHG is a growing, internationally recognized healthcare management, ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... After raising ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established ... of its wildly popular travel innovation to Americans. , “We’re excited to be operating ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... According to ... Americans, yet poor sleep is likely not the only cause of the sunken-eye look, ... that make you look older or in poor health are likely due to genetics, ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... New York , March 23, 2017 /PRNewswire/ ... market exhibits a consolidated vendor landscape with the top ... overall market in 2015. These companies are Stryker ... Inc., Hygia Health Services, Inc., and VANGUARD AG. ... reprocessed medical devices market is witnessing the prevalence ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Israel , March 23, 2017 ... oncology and immunology, announced today that it has acquired Agalimmune ... platform. Acquisition consideration consisted of a $6 million upfront payment, ... in BioLineRx shares. Additional future payments may be made based ... ...
Breaking Medicine Technology: